| Political Editor Berkshire's Political Platform |
| Home |
| Latest News |
| Comment |
| Have Your Say |
| Campaigns |
| Theresa May |
| John Redwood |
| Martin Salter |
| Rob Wilson |
| Links |
|
Salter joins Campaign against Alzheimer's Decision
|
||||||
SALTER JOINS CAMPAIGN AGAINST “CRUEL” ALZHEIMER’S DECISION
Reading West M.P Martin Salter has expressed dismay at the recently published guidance from the National Institute for Clinical Excellence (NICE) to withdraw dementia drugs costing as little as £2.50 a day on the grounds of cost. Mr Salter has joined the campaign led by the Alzheimer’s Society, Age Concern and the Royal College of Nursing to reverse this penny-pinching decision by NICE, and has signed EDM 2323 National Institute for Health and Clinical Excellence’s Final Decision on Alzheimer’s Drugs which argues that the NICE guidance contradicts Government policy on early intervention, support for carers and maintaining independence, and has called for the Department of Health to seriously consider how people with early and late Alzheimer’s should be treated. Last week the appeal against the NICE decision was heard, which highlighted a catalogue of failures by NICE in the way it reached its decision to deny people in the early and late stages of Alzheimer’s disease access to drug treatments. It also condemns the guidance as perverse in light of the scientific evidence available. NICE have admitted that the early stage drugs are clinically effective, and it is likely that withdrawing these drugs will discourage early diagnosis of the condition. Ebixa will be completely withdrawn, despite being proven to reduce the behavioural symptoms which can cause such distress to carers and families. The Alliance also heavily criticises fundamental flaws in the model NICE used to judge the cost-effectiveness of the drugs, which led them to the conclusion that the benefits of the treatments were not worth the cost of £2.50 a day. Martin Salter said: “I have been contacted by many of my constituents who are very distressed that these drugs will be withdrawn. They know from experience that quality of life can be dramatically improved, both for those suffering from dementia and for the people caring for them. NICE’s decision to rob Alzheimer’s sufferers of their dignity and independence is simply cruel” With the results of the appeal soon to be known, I am hopeful that NICE will finally listen to the representations of myself, and the 9000 people who responded to their consultation, and overturn this decision”
|
||||||
|
|